Download presentation
Presentation is loading. Please wait.
Published byBraydon Kirkby Modified over 9 years ago
1
Molecular Targets For Drug Action (syllabus - prof.Kršiak) FOUR MAJOR TARGETS FOR DRUGS: 1. RECEPTORS 2. ION CHANNELS 3. CARRIER MOLECULES 4. ENZYMES
2
Molecular Targets For Drug Action FOUR MAJOR TARGETS FOR DRUGS: 1. RECEPTORS 2. ION CHANNELS 3. CARRIER MOLECULES 4. ENZYMES
3
RECEPTORS Cell Membrane Intracellular - Receptors linked to gene transcription(nuclear receptors) Channel-linked receptors G-protein-coupled receptors Kinase-linked receptors 1. RECEPTORS
4
- about 90% of synapses in the CNS - for fast synaptic transmission (msec) - examples: NICOTINIC, NMDA RECEPTOR: Na + flows into cells, depolarization, excitation GABA A RECEPTOR: Cl - flows into cells, hyperpolarization, inhibition CHANNEL-LINKED RECEPTORS („ionotropic receptors“)
5
CHANNEL-LINKED RECEPTORS („ionotropic receptors“) Katzung 2-12 ale raději GABA A Katzung BG, 2001 Nicotinic receptor pentameric structure - five subunits form a cluster surrounding a central transmembrane pore. When acetylcholine binds, the channel pore opens.
6
GABA A receptor Benzodiazep. receptor
7
- sites for action of about 45% of drugs - for slow synaptic transmission (seconds - minutes) -examples: beta-adrenergic receptors, muscarinic receptors - „coupling“: RECEPTOR - serpentine receptors: a polypeptide chain traverses the membrane seven times G PROTEIN EFFECTOR G-PROTEIN-COUPLED RECEPTORS („metabotropic receptors“)
8
G-PROTEIN-COUPLED RECEPTORS („metabotropic receptors“) Katzung Fig 2-14 Katzung BG, 2001serpentine receptors: a polypeptide chain traverses the membrane seven times, the extracellular terminal (NH 2 ), the intracelullar carboxyl terminal, sites for binding ligands, G-protein
9
G-PROTEIN-COUPLED RECEPTORS („metabotropic receptors“) RECEPTOR G PROTEIN - trimer, , , subunits subunit: GDP GTP, GTPase aktivity stimulation (G S ), inhibition (G I ) of the effector EFFECTOR
10
betagama EFFECTOR Alfa GDP GTP AlfaGTP Alfa GDP EFFECTOR RECEPTOR G-PROTEIN Alfa GDP G-PROTEIN-COUPLED RECEPTORS („metabotropic receptors“) eg. adenylyl cyclase G s beta-adrenergic receptor G i mu opioid receptor Alfa GDP EFFECTOR
11
ENZYM adenylyl cyklase cAMP fosfolipase C IP 3, DAG Proteinkinases G-PROTEIN-COUPLED RECEPTORS („metabotropic receptors“) G-PROTEIN RECEPTOR Ca ++ release 2 nd messengers: Activation/inhibition of cellular functions eg. contractile proteins, enzymes, transporters, ion channels ION CHANNEL
12
Molecular Targets For Drug Action) FOUR MAJOR TARGETS FOR DRUGS: 1. RECEPTORS 2. ION CHANNELS 3. CARRIER MOLECULES 4. ENZYMES
13
2. ION CHANNELS voltage-gated channels calcium channels - Ca ++ flows into cells, calcium channel blockers sodium channels - Na ++ flows into cells, blocked by local anaesthetics ligand-gated channels, G protein-gated*, and other *(directly or by intermediaries),
14
Molecular Targets For Drug Action FOUR MAJOR TARGETS FOR DRUGS: 1. RECEPTORS 2. ION CHANNELS 3. CARRIER MOLECULES 4. ENZYMES
15
3. CARRIER MOLECULES „pumps“ sodium pump - Na + /K + ATPase, „pumps“ Na + from the cell, inhibited by cardiac glycosides proton pump - H + /K + ATPase, „pumps“ H + from the cell, proton pump inhibitors transporters transporters for noradrenaline, serotonine inhibited by most antidepressants (RUI, TCA, SSRI etc)
16
Molecular Targets For Drug Action FOUR MAJOR TARGETS FOR DRUGS: 1. RECEPTORS 2. ION CHANNELS 3. CARRIER MOLECULES 4. ENZYMES
17
sites of action of about 30% of drugs
18
G-protein coupled receptors membr. Voltage gated - Calcium chan. - Sodium chan. „pumps“ - sodium - proton transporters cardiac glykosides PP inhibitors lok. anaesthetetics Calcium ch. blockers about 45% of drugs,e.g. beta-blockers antidepressants ACE inhibitors, IMAO perif. muscle relaxants Examples of drugs:: Enzyme-linked rec. intracelul. Ligand-gated, G-prot.,… ACE, MAO, COX, HMG-CoA reductase Channel-linked receptors 1. RECEPTORS 2. ION CHANNELS 3. CARRIER MOLECULES Molecular mechanisms of drug effects - summary FOUR MAJOR TARGETS FOR DRUGS: 4. ENZYMES
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.